How do you use Canakinumab in a sentence? See 2 example sentences showing how this word appears in different contexts, plus the exact meaning.
Canakinumab in a sentence
Canakinumab meaning
A human monoclonal antibody targeted at interleukin-1 beta, intended to treat rheumatoid arthritis.
Using Canakinumab
- The main meaning on this page is: A human monoclonal antibody targeted at interleukin-1 beta, intended to treat rheumatoid arthritis.
Context around Canakinumab
- Average sentence length in these examples: 15 words
- Position in the sentence: 0 start, 2 middle, 0 end
- Sentence types: 2 statements, 0 questions, 0 exclamations
Corpus analysis for Canakinumab
- In this selection, "canakinumab" usually appears in the middle of the sentence. The average example has 15 words, and this corpus slice is mostly made up of statements.
- Around the word, entresto, actually and inaudible stand out and add context to how "canakinumab" is used.
- Recognizable usage signals include clear that canakinumab actually does and not entresto canakinumab inaudible lung. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "canakinumab" sits close to words such as aabb, aabria and aacha, which helps place it inside the broader word index.
Example types with canakinumab
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
No, no, sorry John, not Entresto, canakinumab (inaudible) lung cancer, first line, second line. (14 words)
At this point, she stressed, it's not clear that canakinumab actually does slow joint degeneration. (16 words)
At this point, she stressed, it's not clear that canakinumab actually does slow joint degeneration. (16 words)
No, no, sorry John, not Entresto, canakinumab (inaudible) lung cancer, first line, second line. (14 words)
Example sentences (2)
At this point, she stressed, it's not clear that canakinumab actually does slow joint degeneration.
No, no, sorry John, not Entresto, canakinumab (inaudible) lung cancer, first line, second line.